VolitionRx Statistics

Total Valuation

VolitionRx has a market cap or net worth of $46.99 million. The enterprise value is $48.90 million.

Market Cap	46.99M
Enterprise Value	48.90M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

VolitionRx has 96.54 million shares outstanding. The number of shares has increased by 21.47% in one year.

Current Share Class	96.54M
Shares Outstanding	96.54M
Shares Change (YoY)	+21.47%
Shares Change (QoQ)	+6.53%
Owned by Insiders (%)	7.86%
Owned by Institutions (%)	13.69%
Float	66.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.67
Forward PS	6.70
PB Ratio	-1.77
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	39.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.52

Current Ratio	0.52
Quick Ratio	0.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-79.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-90.44%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-1,679.85%
Revenue Per Employee	$14,512
Profits Per Employee	-$317,269
Employee Count	85
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.88% in the last 52 weeks. The beta is 1.16, so VolitionRx's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-18.88%
50-Day Moving Average	0.55
200-Day Moving Average	0.63
Relative Strength Index (RSI)	41.16
Average Volume (20 Days)	299,981

Short Selling Information

The latest short interest is 690,559, so 0.72% of the outstanding shares have been sold short.

Short Interest	690,559
Short Previous Month	583,671
Short % of Shares Out	0.72%
Short % of Float	1.04%
Short Ratio (days to cover)	5.11

Income Statement

In the last 12 months, VolitionRx had revenue of $1.23 million and -$26.97 million in losses. Loss per share was -$0.31.

Revenue	1.23M
Gross Profit	1.23M
Operating Income	-27.02M
Pretax Income	-34.91M
Net Income	-26.97M
EBITDA	-25.91M
EBIT	-27.02M
Loss Per Share	-$0.31

Full Income Statement

Balance Sheet

The company has $3.26 million in cash and $5.82 million in debt, giving a net cash position of -$2.56 million or -$0.03 per share.

Cash & Cash Equivalents	3.26M
Total Debt	5.82M
Net Cash	-2.56M
Net Cash Per Share	-$0.03
Equity (Book Value)	-26.11M
Book Value Per Share	-0.26
Working Capital	-3.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.89 million and capital expenditures -$277,499, giving a free cash flow of -$26.17 million.

Operating Cash Flow	-25.89M
Capital Expenditures	-277,499
Free Cash Flow	-26.17M
FCF Per Share	-$0.27

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,190.90%
Pretax Margin	-2,209.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VolitionRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.47%
Shareholder Yield	-21.47%
Earnings Yield	-58.19%
FCF Yield	-56.48%

Analyst Forecast

The average price target for VolitionRx is $3.75, which is 670.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.75
Price Target Difference	670.50%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	176.02%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VolitionRx has an Altman Z-Score of -42.94 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-42.94
Piotroski F-Score	2